Cancer immunotherapy is one of the newest and most promising of cancer treatments.
Some forms of cancer can become resistant to hormone therapy.
Celebrating the 10th Anniversary of Cancer Research at the University of Surrey On 29th January 2016, the Prostate Project celebrated 10 years of campaigning which has helped put Surrey at the forefront of the fight against cancer. In 2006 the Prostate Project jointly established and funded a research group with the University of Surrey, led by
Clinical trials have found that the EN2 biomarker test is twice as effective as the PSA blood test currently used to detect prostate cancer.
Potential targets for novel therapies include proteins involved in cell growth and signalling within the cell.